Joint (NASDAQ:JYNT) Rating Increased to Strong-Buy at Wall Street Zen

Joint (NASDAQ:JYNT) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday.

JYNT has been the subject of a number of other research reports. Zacks Research upgraded shares of Joint from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 12th. Weiss Ratings raised shares of Joint from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Joint currently has a consensus rating of “Hold” and an average price target of $18.00.

Joint Price Performance

Shares of JYNT opened at $8.90 on Friday. Joint has a 1-year low of $7.50 and a 1-year high of $13.47. The company has a 50-day moving average of $8.75 and a 200 day moving average of $8.88. The firm has a market capitalization of $126.87 million, a price-to-earnings ratio of 38.70 and a beta of 1.11.

Joint (NASDAQ:JYNT) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. Joint had a net margin of 5.72% and a return on equity of 7.00%. The company had revenue of $14.82 million during the quarter, compared to analyst estimates of $14.50 million. On average, equities analysts anticipate that Joint will post 0.51 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Joint news, major shareholder Charles E. Jobson bought 127,676 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were acquired at an average price of $8.57 per share, with a total value of $1,094,183.32. Following the transaction, the insider owned 1,773,479 shares of the company’s stock, valued at approximately $15,198,715.03. This trade represents a 7.76% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 30.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of JYNT. JCP Investment Management LLC purchased a new position in shares of Joint in the 2nd quarter worth approximately $5,526,000. Clayton Partners LLC purchased a new position in shares of Joint in the 4th quarter worth approximately $1,652,000. Russell Investments Group Ltd. grew its position in shares of Joint by 77.3% in the 4th quarter. Russell Investments Group Ltd. now owns 205,411 shares of the company’s stock worth $1,791,000 after buying an additional 89,526 shares during the last quarter. First Foundation Advisors grew its position in shares of Joint by 47.8% in the 3rd quarter. First Foundation Advisors now owns 273,759 shares of the company’s stock worth $2,612,000 after buying an additional 88,486 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new position in shares of Joint in the 4th quarter worth approximately $766,000. Hedge funds and other institutional investors own 76.88% of the company’s stock.

Joint Company Profile

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.